Blog

Against the challenging backdrop of a global pandemic, 2020 saw the successful merger of UKI2S portfolio company Perfectus Biomed and US-based Extherid Biosciences. There are of course specific challenges for a UK/US merger, but the value of cross-cultural collaboration across all levels of the business should be celebrated particularly for the personal growth and development […]

read more

Completing a UK/US merger can be a complicated and demanding undertaking at the best of times, let alone during a global pandemic. However, for UKI2S portfolio company Perfectus Biomed, and US-based Extherid Biosciences, this unique situation brought unforeseen advantages. We spoke to Sam Westgate, CEO, Perfectus Biomed, and Marnie Peterson, CEO, Extherid Biosciences, to learn […]

read more

Many companies set their sights on the large and lucrative US market, and those developing products based on synthetic biology are no exception. However, this isn’t as straightforward as it sounds. According to a report published by the Synthetic Biology Project at the Woodrow Wilson International Center for Scholars, the path to approval for these […]

read more

1 2